Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 329,503 | 885,562 | 131,434 | 131,689 | 204,505 |
| Marketable Securities | 957,660 | 504,544 | 447,616 | 514,021 | 490,855 |
| Other current assets | 16,347 | 13,537 | 16,341 | 8,327 | 9,456 |
| TOTAL | $1,303,510 | $1,403,643 | $595,391 | $654,037 | $704,816 |
| Non-Current Assets | |||||
| PPE Net | 9,061 | 7,809 | 5,901 | 3,187 | 2,283 |
| Investments And Advances | 11,676 | 15,629 | 11,400 | 0 | 0 |
| Other Non-Current Assets | 56,585 | 49,047 | 7,159 | 6,726 | 6,348 |
| TOTAL | $77,322 | $72,485 | $24,460 | $9,913 | $8,631 |
| Total Assets | $1,380,832 | $1,476,128 | $619,851 | $663,950 | $713,447 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 18,117 | 66,670 | 56,843 | 55,450 |
| Accrued Expenses | N/A | 53,355 | N/A | N/A | N/A |
| TOTAL | $77,105 | $71,472 | $67,367 | $57,695 | $56,047 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 697 | 852 | 597 |
| Other Non-Current Liabilities | 44,314 | 43,867 | 1,541 | 1,251 | 1,174 |
| TOTAL | $44,314 | $43,867 | $1,541 | $1,251 | $1,174 |
| Total Liabilities | $121,419 | $115,339 | $68,908 | $58,946 | $57,221 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,440 | 50,634 | 50,281 | 44,541 | 43,642 |
| Common Shares | 51 | 50 | 45 | 45 | 44 |
| Retained earnings | -1,265,918 | -1,130,238 | -1,029,151 | -941,815 | -858,956 |
| Other shareholders' equity | 9,456 | 9,759 | 10,457 | 11,284 | 9,707 |
| TOTAL | $1,259,413 | $1,360,789 | $550,943 | $605,004 | $656,226 |
| Total Liabilities And Equity | $1,380,832 | $1,476,128 | $619,851 | $663,950 | $713,447 |